Edwards Lifesciences (NYSE:EW) Upgraded at Oppenheimer
0 Comments

Oppenheimer upgraded shares of Edwards Lifesciences (NYSE:EW) from a market perform rating to a buy rating in a research note issued to investors on Thursday morning, Briefing.com Automated Import reports. They currently have $280.00 price objective on the medical research company’s stock.

Edwards Lifesciences (NYSE:EW) Upgraded at Oppenheimer

Donald E. Bobo, Jr. Sells 5,369 Shares of Edwards Lifesciences Corp (NYSE:EW) Stock

Diversified Trust Co Has $1.21 Million Holdings in Edwards Lifesciences Corp (NYSE:EW)

 



Edwards Lifesciences Corp (NYSE:EW) VP Larry L. Wood Sells 8,568 Shares

Insider Selling: Edwards Lifesciences Corp (NYSE:EW) CFO Sells $1,756,875.00 in Stock

Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Oppenheimer

Author

mukeshathavale.manzi@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *